Kalaris Therapeutics Stock (NASDAQ:KLRS)
Previous Close
$4.16
52W Range
$2.14 - $11.88
50D Avg
$5.39
200D Avg
$6.66
Market Cap
$81.54M
Avg Vol (3M)
$84.27K
Beta
0.14
Div Yield
-
KLRS Company Profile
Kalaris Therapeutics Inc. operates as a pharmaceutical enterprise. The company's core mission centers on developing innovative cell therapies. These treatments are designed to reactivate the body's inherent immunity against critical, virus-linked diseases, especially in patients with profoundly compromised immune systems.